Mass drug showdown: which treatment better fights river blindness?
NCT ID NCT07145736
Summary
This large study in Angola compares two approved drugs—moxidectin and ivermectin—to see which works better when given annually to entire communities to control river blindness. Researchers will treat 52,000 people across 20 village groups for four years to measure how well each drug reduces infections and prevents disease spread. The results will help guide global efforts to eliminate river blindness and control related parasitic infections like intestinal worms and scabies.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HOOKWORM INFECTIONS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Villages in Andulo and Nharea Municipalities
RECRUITINGAndulo, Bíe Province, Angola
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.